The Exchange had sought clarification from Sun Pharmaceutical Industries with respect to news appearing in Business Standard on April 21, 2015 that Daichi Sankyo to exit Company and Promoter Dilip Sanghvi may buy partial stake for 22500 crs .Sun Pharmaceutical Industries replied stating that with respect to your query below regarding purchase of shares of our Company by our promoter, Dilip Shanghvi from Daiichi Sankyo, they hereby state and confirm that the promoter, Dilip Shanghvi has neither purchased nor agreed to purchase any shares of our Company in the said transaction.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1670.00 |
| Dr. Reddys Lab | 1223.40 |
| Cipla | 1231.75 |
| Zydus Lifesciences | 929.70 |
| Lupin | 2327.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: